About
Lewis holds a B.A. from Oberlin College and an M.B.A. and J.D. from Case Western Reserve University. He worked in the U.S. Government Foreign Service from 1989 to 1992 and at JP Morgan Chase from 1995 to 2000. He then worked at Robertson Stephens Capital from 2000 to 2002 and Wells Fargo from 2002 to 2004, before helping start Aegerion in 2005. He advised the Insmed board from June to September 2012 before taking the CEO role. Other biotech and pharmaceutical chief executives with pages on Whoo include Michael Morrissey of Exelixis and Reshma Kewalramani of Vertex Pharmaceuticals.
Whoo compiled this page from public sources: Insmed 2026 proxy statement (SEC), Insmed Q3 2026 results filing (SEC), Insmed Form 10-K, 2025 (SEC). It is not affiliated with or endorsed by Will Lewis. Are you Will Lewis? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chair and Chief Executive Officer — Insmed
2012 – Present | Bridgewater, New Jersey
- President and CEO from 2012 to 2018; Chair and CEO since November 2018
Co-founder, President and Chief Financial Officer — Aegerion Pharmaceuticals
2005 – 2011
Wells Fargo & Co.
2002 – 2004
Robertson Stephens Capital
2000 – 2002
JP Morgan Chase & Co.
1995 – 2000
U.S. Government Foreign Service
1989 – 1992